The Cooper Companies, Inc. operates in both the CooperVision and CooperSurgical segments. This diverse business model provides it with a wide market reach in vision correction and women's health care. With its innovative product offerings, the company continues to exhibit potential for growth in the medical devices sector.
The current fundamental analysis of The Cooper Companies, Inc. shows a range of performance across different financial metrics. Here’s a breakdown of the ratings:
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow (DCF) | 4 | |
| Return on Equity (ROE) | 3 | |
| Return on Assets (ROA) | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings (P/E) | 2 | |
| Price to Book (P/B) | 4 |
Comparing The Cooper Companies, Inc.'s current and past scores offers insight into its financial trajectory:
| Date | Overall Score | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-10-14 | 3 | 4 | 3 | 5 | 1 | 2 | 4 |
| Previous | 0 | 4 | 3 | 5 | 1 | 2 | 4 |
Analyst estimates indicate a positive outlook with varied price target evaluations:
| High | Low | Median | Consensus |
|---|---|---|---|
| $100 | $64 | $85 | $84.14 |
The overall sentiment from analysts shows a tendency towards holding and buying:
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 15 | |
| Hold | 7 | |
| Sell | 1 | |
| Strong Sell | 0 |
The Cooper Companies, Inc. demonstrates strong potential in the healthcare sector with a robust product lineup in both vision and women's health segments. Despite the mix of fundamental scores, the company’s innovative stance and market reach merit a favorable outlook. Analyst sentiments align with a generally positive perception, underlined by a strong buy signal. However, the company's debt levels and valuation ratios need close monitoring to mitigate any financial risks. In conclusion, while there are challenges to address, the potential growth prospects remain noteworthy.